38 active not recruiting. 38 Phase 3, 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 38 | Active not recruiting 38 |
| Phase 2 | 7 | Active not recruiting 7 |
Follow Mr Imaging: new trials by email Literature Review of Mr Imaging trials Research Report on Mr Imaging
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial Best Practice, Biospecimen Collection, Bone Metastases Treatment - Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Solid Neoplasm | Phase 3 | Active not recruiting | NRG Oncology | 280 | 2025-05-07 | 2026-08-17 |
| Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain Computed Tomography, Fractionated Stereotactic Radiation Therapy, Magnetic Resonance Imaging - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma | Phase 3 | Active not recruiting | NRG Oncology | 274 | 2024-12-12 | 2026-09-14 |
| Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study Computed Tomography, Magnetic Resonance Imaging, Questionnaire Administration - Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 | Phase 3 | Active not recruiting | ECOG-ACRIN Cancer Research Group | 472 | 2023-12-27 | 2026-09-15 |
| Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck Carboplatin, Cisplatin, Computed Tomography - Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma | Phase 3 | Active not recruiting | ECOG-ACRIN Cancer Research Group | 290 | 2023-06-08 | 2026-09-14 |
| Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working Biospecimen Collection, Bone Scan, Computed Tomography - Locally Advanced Uterine Corpus Leiomyosarcoma, Metastatic Uterine Corpus Leiomyosarcoma | Phase 2 / Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 74 | 2023-03-30 | 2026-10-01 |
| Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers Atezolizumab, Bevacizumab, Biospecimen Collection - Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma | Phase 2 / Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 430 | 2023-03-13 | 2026-11-03 |
| Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative Biopsy Procedure, Biospecimen Collection, Computed Tomography - Lung Adenocarcinoma, Lung Adenosquamous Carcinoma | Phase 2 / Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 427 | 2022-10-07 | 2026-10-01 |
| Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study Avelumab, Biospecimen Collection, Bone Scan - Advanced Bladder Urothelial Carcinoma, Advanced Renal Pelvis Urothelial Carcinoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 654 | 2022-06-03 | 2026-10-26 |
| A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor Biospecimen Collection, Cognitive Assessment, Magnetic Resonance Imaging - Central Nervous System Carcinoma | Phase 3 | Active not recruiting | Children's Oncology Group | 162 | 2022-05-10 | 2026-07-13 |
| Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma Lomustine, Magnetic Resonance Imaging, Photon Beam Radiation Therapy - Glioblastoma, Gliosarcoma | Phase 3 | Active not recruiting | NRG Oncology | 265 | 2022-03-28 | 2026-08-17 |
| Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer Cisplatin, Computed Tomography, Magnetic Resonance Imaging - Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma | Phase 2 / Phase 3 | Active not recruiting | NRG Oncology | 475 | 2022-02-01 | 2026-10-23 |
| A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma | Phase 3 | Active not recruiting | Children's Oncology Group | 113 | 2021-09-14 | 2026-07-30 |
| Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer Biospecimen Collection, Bone Scan, Computed Tomography - Metastatic Bladder Urothelial Carcinoma, Metastatic Urothelial Carcinoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 131 | 2021-06-28 | 2026-11-02 |
| Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability Biospecimen Collection, Magnetic Resonance Imaging, Memantine Hydrochloride - Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain | Phase 3 | Active not recruiting | NRG Oncology | 152 | 2021-06-08 | 2026-09-14 |
| A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma Biospecimen Collection, Magnetic Resonance Imaging, Quality-of-Life Assessment - Recurrent Low Grade Astrocytoma, Recurrent WHO Grade 2 Glioma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 300 | 2021-02-16 | 2026-07-02 |
| S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer Magnetic Resonance Imaging, Prophylactic Cranial Irradiation - Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma | Phase 3 | Active not recruiting | SWOG Cancer Research Network | 668 | 2020-05-04 | 2026-06-11 |
| Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial Apalutamide, Biospecimen Collection, Bone Scan - Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 | Phase 3 | Active not recruiting | NRG Oncology | 586 | 2020-04-16 | 2026-08-17 |
| Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer Biospecimen Collection, Brachytherapy, Computed Tomography - Endometrial Endometrioid Adenocarcinoma, Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 164 | 2020-04-09 | 2026-07-02 |
| A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma Carboplatin, Magnetic Resonance Imaging, Quality-of-Life Assessment - Low Grade Glioma, Neurofibromatosis Type 1 | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 165 | 2020-01-15 | 2026-08-13 |
| De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer Biopsy Procedure, Biospecimen Collection, Cisplatin - Basaloid Squamous Cell Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 2 / Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 384 | 2019-10-09 | 2026-07-02 |
Showing 20 of 38. Sign in to see all of them.
Carcinoma, Renal Cell (4) · Lung Neoplasms (4) · Oropharyngeal Neoplasms (4) · Carcinoma (3) · Squamous Cell Carcinoma of Head and Neck (3) · Urinary Bladder Neoplasms (3) · Brain Neoplasms (2) · Breast Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (2) · Fallopian Tube Neoplasms (2) · Hypopharyngeal Neoplasms (2) · Laryngeal Neoplasms (2) · Melanoma (2) · Mouth Neoplasms (2) · Nasopharyngeal Carcinoma (2)
National Cancer Institute (NCI) (24) · NRG Oncology (8) · Children's Oncology Group (3) · ECOG-ACRIN Cancer Research Group (2) · SWOG Cancer Research Network (1)
United States (38) · Canada (21) · Puerto Rico (11) · Saudi Arabia (4) · Australia (3) · Hong Kong (3) · Ireland (3) · Japan (3) · South Korea (3) · Guam (2) · Chile (1) · China (1) · Colombia (1) · Germany (1) · India (1)
Aarti Bhatia (1) · Alex F Herrera (1) · Andrea B Apolo (1) · Chad G Rusthoven (1) · Christine M Bestvina (1) · Daniel C Bowers (1) · David J Sher (1) · Erin F Gillespie (1) · Fabio M Iwamoto (1) · Floor Backes (1) · Frank A Sinicrope (1) · Holly J Meany (1) · Hossein Borghaei (1) · Janice Mehnert (1)
PMID 33152282, PMID 33395032, PMID 34340209, PMID 34357781, PMID 35170751, PMID 35290101, PMID 35304832, PMID 35383907, PMID 35613998, PMID 36416836, PMID 37185961, PMID 37505794, PMID 38421243, PMID 38531002, PMID 38945791, PMID 39146945, PMID 39282902, PMID 39282913, PMID 39361946, PMID 39413375, PMID 39938471, PMID 40953502, PMID 40966692, PMID 41512237, PMID 41524552, PMID 41825136, PMID 41880612, PMID 42525921, PMID 42526889, PMID 42577949
U10CA180868 (11), U10CA180820 (8), U10CA180821 (7), U10CA180888 (5), U10CA180886 (4), U10CA021115 (2), U24CA196172 (2), UG1CA189867 (2), U01CA246568 (1), U10CA021661 (1), U10CA098543 (1), U10CA180830 (1), U24CA196173 (1), UG1CA189955 (1)